NY A05603 | 2019-2020 | General Assembly

Status

Spectrum: Moderate Partisan Bill (Democrat 15-2)
Status: Introduced on February 13 2019 - 25% progression, died in committee
Action: 2020-01-08 - referred to ways and means
Pending: Assembly Ways and Means Committee
Text: Latest bill text (Amended) [HTML]

Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in over 50 morphine milligram equivalents per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

Sponsors


Roll Calls

2019-06-13 - Assembly - Assembly Health Committee: Favorable refer to committee Ways and Means (Y: 26 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2020-01-08Assemblyreferred to ways and means
2019-06-13Assemblyprint number 5603b
2019-06-13Assemblyamend and recommit to ways and means
2019-06-13Assemblyreported referred to ways and means
2019-05-22Assemblyprint number 5603a
2019-05-22Assemblyamend (t) and recommit to health
2019-02-13Assemblyreferred to health

Same As/Similar To

S05150 (Same As) 2020-02-04 - referred to ways and means

New York State Sources


Bill Comments

feedback